Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
出版年份 2021 全文链接
标题
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination
作者
关键词
-
出版物
Diagnostics
Volume 11, Issue 5, Pages 832
出版商
MDPI AG
发表日期
2021-05-05
DOI
10.3390/diagnostics11050832
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Messenger RNA vaccines against SARS-CoV-2
- (2021) Eric J. Topol CELL
- COVID-19 vaccines: where we stand and challenges ahead
- (2021) Guido Forni et al. CELL DEATH AND DIFFERENTIATION
- Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination
- (2021) Giuseppe Lippi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
- (2021) Kamal Abu Jabal et al. Eurosurveillance
- Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines
- (2021) Edward H. Livingston JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
- (2021) Saman Saadat et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
- (2021) Maria Prendecki et al. LANCET
- Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
- (2021) Zimei Wu et al. PHARMACEUTICAL RESEARCH
- Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
- (2021) Federico Gobbi et al. Viruses-Basel
- Defer vaccination of people who have had covid-19
- (2021) Raj Bhopal BMJ-British Medical Journal
- SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
- (2021) Emily Bettini et al. Vaccines
- Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy
- (2021) Agnese Comelli et al. Microorganisms
- Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
- (2021) Anja Dörschug et al. Diagnostics
- Age‐dependent and gender‐dependent antibody responses against SARS‐CoV ‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine
- (2021) Evangelos Terpos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
- (2021) Elisa Danese et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents
- (2021) Jens T Van Praet et al. CLINICAL INFECTIOUS DISEASES
- Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
- (2021) Ayelet Grupper et al. Clinical Journal of the American Society of Nephrology
- Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
- (2021) Sathyavani Subbarao et al. Eurosurveillance
- COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
- (2021) Marie Tré-Hardy et al. JOURNAL OF INFECTION
- Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID‐A study
- (2021) Sergio Salmerón Ríos et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?
- (2021) Patrick L Iversen et al. LANCET INFECTIOUS DISEASES
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
- (2021) Yaniv Lustig et al. NEW ENGLAND JOURNAL OF MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- The story behind COVID-19 vaccines
- (2021) Anthony S. Fauci SCIENCE
- Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated with Belatacept
- (2021) Nathalie Chavarot et al. TRANSPLANTATION
- Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
- (2021) Lorenzo Azzi et al. VACCINE
- Frailty as a predictor of mortality among patients with COVID-19: a systematic review and meta-analysis
- (2021) Xiao-Ming Zhang et al. BMC Geriatrics
- How will emerging SARS-CoV-2 variants impact herd immunity?
- (2021) Giuseppe Lippi et al. Annals of Translational Medicine
- Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines
- (2021) Bogdan Doroftei et al. Diagnostics
- Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
- (2021) Thomas Mueller CLINICA CHIMICA ACTA
- Role of nanotechnology behind the success of mRNA vaccines for COVID-19
- (2021) Amit Khurana et al. Nano Today
- COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
- (2020) Giuseppe Lippi et al. Annals of Translational Medicine
- IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2
- (2020) Mary Kathryn Bohn et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Coronavirus vaccine? Join the queue
- (2020) The Lancet Diabetes & Endocrinology Lancet Diabetes & Endocrinology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search